AR and breast carcinoma: Notably, in the breast cancer cell lines, androgen receptor (AR) is weakly, positively correlated with PART1, whereas in breast cancer patient tumors, AR is significantly negatively correlated with PART1 (Figure 1E,F), potentially suggesting a cell culturing-dependent effect.